Research Articles | Page 81 | Aplastic Anemia & MDS International Foundation Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial Jul 2023 Lancet myelodysplastic syndromes (MDS)
Efficacy and Safety of Lenalidomide for Treatment of Low-/Intermediate-1-Risk Myelodysplastic Syndromes with or without 5q Deletion: A Systematic Review and Meta-Analysis Nov 2016 PLoS One myelodysplastic syndromes (MDS)
Efficacy and safety of extended dosing schedules of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes Oct 2015 Leukemia myelodysplastic syndromes (MDS)
Efficacy and safety of eculizumab in children and adolescents with paroxysmal nocturnal hemoglobinuria Apr 2014 Pediatr Blood Cancer paroxysmal nocturnal hemoglobinuria (PNH)
Efficacy and safety of deferasirox in myelodysplastic syndromes Feb 2013 Ann Hematol myelodysplastic syndromes (MDS)
Efficacy and safety of darbepoetin alpha in patients with myelodysplastic syndromes: a systematic review and meta-analysis May 2016 Br J Haematol myelodysplastic syndromes (MDS)
Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry Jan 2019 Am J Hematol aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH)
Effectiveness of azacitidine in higher-risk myelodysplastic syndromes May 2016 Leukemia myelodysplastic syndromes (MDS)
Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry Sep 2015 Leukemia myelodysplastic syndromes (MDS)
Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series Jan 2021 Annals of Hematology aplastic anemia
Share with addtoany.com.